Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trialAlison Luckey, Henry J.C. de Vries, Jodie Dionne‐Odom et al.|The Lancet|2025Cited by 26
Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I <scp>open‐label</scp> randomized cross‐over study in healthy subjectsAlison Luckey, Jean‐Yves Gillon, Emilie Alirol et al.|Clinical and Translational Science|2023Cited by 6
Microbiological analysis and whole-genome sequencing of Neisseria gonorrhoeae from the microbiological failures in the international, zoliflodacin, phase 3, clinical trial for treatment of uncomplicated urogenital gonorrhoea: a retrospective, genomic, observational studyMagnus Unemo, Alison Luckey, Varalakshmi Elango et al.|The Lancet Microbe|2026Cited by 4
Evaluation of Drug–Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the <scp>CYP3A4</scp> Inhibitor Itraconazole: A Phase 1 Study in Healthy ParticipantsAlison Luckey, Jean-Yves Gillon, Kajal Larson et al.|Clinical and Translational Science|2026Cited by 0